LOS ANGELES, March 6, 2014 /PRNewswire/ — Verde Media Biotechnology Division (“VMBD”) is in the advance negotiation stage for acquisition and partnership with a Massachusetts based technology-developing company for the production of high value bio-products. The target company has developed a microbial technology platform for the production of omega-3 fatty acids (EPA and DHA) using economical and abundantly available feedstock. The alternative fermentation based process can convert sugars and organic waste products to omega-3 oils with high yields and specificity and therefore open new supply chains. Furthermore, the process is capable of producing high titre and concentration of omega-3 oils in the fermentation vessel.
The new platform technologies can achieve 500-800% increase in DHA levels in the microbial oils compared to fish derived oils. As a result, the microbial derived omega-3 oils have a niche place in the several billion-dollar cosmetic and medicinal markets. The development is in line with an increasing trend in demand mainly in the aquaculture industry ($100 billion) and food supplements ($30B).
Dr. Abidi, Ph.D. CEO of VMBD stated, “We are excited with the addition of another high value bio-product to our growing portfolio of acquisition targets. The ability to convert sugar and non-sugar feedstock to omega-3 oil is more efficient than converting carbon dioxide gas to oils and provides a competitive advantage to all other technologies. Furthermore, carbohydrate to omega-3 oil is a sustainable, renewable and eco-friendly process that can be rapidly scaled-up to commercial production.”
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI. Verde Media Group Inc. The company is consists of three divisions:
Agency Division– The innovative Agency division services- public relations, marketing, and transaction functions for corporate clientele. The agency is rapidly expanding its business in the Denver, Colorado market that will become the largest retail marijuana sector currently legitimized.
BioTech Division– The VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock. VMBD will further develop the derivative and ester forms of THC for increase potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.
Entertainment Division– The company operates a managed media company with production, distribution, development, and acquisition functions for film and television.
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The results described herein cannot be guaranteed. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are “forward-looking statements” that are based on current expectations and assumptions.
SOURCE Verde Media Group, Inc.